By combining ensemble cryo-EM, deep learning, and molecular docking screens, the Apple Tree Partners backed start-up is identifying hits that promote signaling in GPCRs and other target classes
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,